We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIq-ai Ltd Regulatory News (IQAI)

Share Price Information for Iq-ai Ltd (IQAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.60
Bid: 1.50
Ask: 1.70
Change: 0.10 (6.67%)
Spread: 0.20 (13.333%)
Open: 1.50
High: 1.625
Low: 1.50
Prev. Close: 1.50
IQAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

13 Jun 2012 10:25

RNS Number : 2670F
Flying Brands Limited
13 June 2012
 



13 June 2012

 

FLYING BRANDS LIMITED

 

RESULT OF ANNUAL GENERAL MEETING

 

The Board of Flying Brands Limited (the "Company") is pleased to announce that at the Company's Annual General Meeting held on Wednesday 13 June 2012 (the "AGM") the resolutions as set out in the Notice of AGM were duly passed on a show of hands.

 

The following levels of proxy appointments were received by the Company prior to the AGM:

 

Resolution

For

Against

Chairman's discretion (Note i)

Votes withheld

Number of shares

% of total

Number of shares

% of total

Number of shares

% of total

To receive and adopt the report and accounts

 

8,306,747

52.25

21,846

0.14

7,568,575

47.61

1,110,300

To approve the Remuneration Committee Report

 

9,345,865

55.05

62,652

0.37

7,569,070

44.58

29,881

To re-appoint John Henwood as a director

 

9,376,637

55.15

56,235

0.33

7,570,059

44.52

4,537

To re-appoint Paul Davidson as a director

 

9,376,521

55.15

55,951

0.33

7,570,059

44.52

4,937

To appoint Stuart Dootson as a director

 

9,408,751

55.34

24,121

0.14

7,570,059

44.52

4,537

To re-appoint Deloitte LLP as auditor and to authorise the directors to determine their remuneration

 

6,256,572

36.8

8,645

0.05

10,738,785

63.15

3,196

Special Resolution - To authorise the directors to make market purchases of ordinary shares

 

6,225,475

36.61

41,155

0.24

10,738,785

63.15

1,783

Special Resolution - To authorise the directors to allot ordinary shares without rights of pre-emption

4,153,661

24.43

2,112,606

12.42

10,738,785

63.15

2,146

 

Notes:

(i) Proxy appointments which gave discretion to the Chairman have been cast in favour of each resolution.

 

(ii) Issued share capital at 13 June 2012: 28,073,735 ordinary shares. Proxy appointments were received from shareholders holding the number of shares shown below, in each case representing the percentage of the issued share capital shown alongside:

 

Resolution 1

15,897,168 shares

56.63%

Resolution 2

16,977,587 shares

60.47%

Resolution 3

17,002,931 shares

60.56%

Resolution 4

17,002,531 shares

60.56%

Resolution 5

17,002,931 shares

60.56%

Resolution 6

17,004,272 shares

60.57%

Resolution 7

17,005,685 shares

60.57%

Resolution 8

17,005,322 shares

60.57%

 

 

(iii) A "Vote Withheld" is not counted towards the votes cast "For" or "Against" the resolutions.

 

For further information, please contact:

 

Flying Brands Limited 01245 228 300

Stephen Cook, Chief Executive

Stuart Dootson, Group Finance Director

 

Smithfield Consultants 020 7360 4900

John Kiely

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGFJMLTMBTBMJT
Date   Source Headline
29th Apr 20243:26 pmRNSPublication of Annual Report
5th Mar 20247:00 amRNSGrant of Options
1st Mar 20248:22 amRNSHolding(s) in Company
1st Mar 20248:20 amRNSHolding(s) in Company
26th Feb 20247:00 amRNSResult of Broker Option and Total Voting Rights
22nd Feb 20247:00 amRNSPlacing and Broker Option
9th Feb 202412:49 pmRNSFDA Application Update
2nd Feb 20248:39 amRNSIB awarded a $100,000 grant
22nd Jan 202410:05 amRNSHolding(s) in Company
15th Jan 20247:01 amRNSDirector Dealings and Conversion of CLNs
15th Jan 20247:00 amRNSHolding(s) in Company
10th Jan 20247:00 amRNSIB Launching an Expanded Access Program for GaM
19th Dec 20232:29 pmRNSImaging Biometrics granted FDA “Fast-Track”
5th Dec 202310:58 amRNSIQ-AI Announces Positive Interim Phase 1 Results
20th Nov 20231:42 pmRNSHolding(s) in Company
9th Nov 202311:38 amRNSDirector Dealing and Conversion of CLNs
8th Nov 202310:59 amRNSApplication for Pediatric Rare Disease Designation
6th Nov 20231:02 pmRNSHolding(s) in Company
18th Oct 20232:29 pmRNSUpdate Regarding Imaging Biometrics LLC
13th Oct 20238:55 amRNSIB Letter to Shareholders
9th Oct 20237:00 amRNSOrphan Drug Status to GaM and Total Voting Rights
3rd Oct 202311:30 amRNSHolding(s) in Company
19th Sep 20232:32 pmRNSIQ-AI shares cease trading on the OTCQB
8th Sep 20237:00 amRNSReduced Gadolinium Approach Validated'
18th Aug 202312:06 pmRNSUpdate on Collaboration Agreement with Mayo Clinic
18th Aug 202311:20 amRNSIB & GE HealthCare Enter into Commercial Agreement
17th Aug 20237:00 amRNSHalf-year Report
19th Jul 20237:00 amRNSImaging Biometrics Installs IB Nimble™ For MCW
13th Jul 20237:00 amRNSOrphan Drug Designation for GaM in Pediatric GBM
27th Jun 20237:00 amRNSStudies Show GaM Inhibits Pediatric Tumor Growth
23rd May 202311:02 amRNSResult of AGM
23rd May 20237:00 amRNSAGM Statement
3rd May 20234:14 pmRNSNotice of AGM
26th Apr 20237:00 amRNSFinal Results
28th Feb 20233:52 pmRNSOrphan Drug Designation Status
13th Jan 20232:05 pmRNSSecond Price Monitoring Extn
13th Jan 20232:00 pmRNSPrice Monitoring Extension
13th Jan 202311:05 amRNSSecond Price Monitoring Extn
13th Jan 202311:00 amRNSPrice Monitoring Extension
10th Jan 20237:00 amRNSLetter to Shareholders
2nd Dec 202211:11 amRNSHolding in Company
25th Oct 202211:00 amRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSLetter to Shareholders
26th Sep 20227:00 amRNSIssue of Warrants to Employees
16th Aug 20224:40 pmRNSSecond Price Monitoring Extn
16th Aug 20224:35 pmRNSPrice Monitoring Extension
16th Aug 20229:28 amRNSHalf-year Report
3rd Aug 20221:01 pmRNSTR1 - Notification of Major Holdings
11th Jul 20227:00 amRNSImaging Biometrics Announces Channel Partnership
31st May 202211:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.